Sponsor Pipeline

Dongguan People's Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
5
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-10 NCT07754734 STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07643636 Chidamide, Venetoclax, Azacitidine, and Homoharringtonine for High-risk Fit AML AML (Acute Myeloid Leukemia) Not Yet Recruiting
NCT07677475 MRG003 Plus Toripalimab Versus Toripalimab as Neoadjuvant Therapy for PD-L1-Positive… Head and Neck Squamous Cell Carcinoma Not Yet Recruiting
NCT07754734 STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT… Glioma Not Yet Recruiting
Disease Areas
Leukemia (1) Acute Myeloid Leukemia (AML) (1) Head & Neck Cancer (1) Glioblastoma (1) Glioma (1)
Get alerts when Dongguan People's Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free